Skip to main content
Screener/Healthcare/Biotechnology

XERS — Xeris Biopharma Holdings, Inc.

NASDAQ
$10.65-0.10 (-0.88%)
Small CapUnder $20HealthcareFastest GrowingHigh ROE
$5.25
$11.41
$10.52
$10.88
EPS (TTM)$0.07
P/E Ratio163.92
Dividend Yield—
Market Cap$1.86B
Volume955K
Prev Close$10.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$83.1M$2.2M$0.010.0%2.7%
Q4 '25$85.8M$11.1M$0.0677.8%12.9%
Q3 '25$74.4M$621K$0.0085.2%0.8%
Q2 '25$71.5M-$1.9M$-0.0179.6%-2.7%
Q1 '25$60.1M-$9.2M$-0.0685.5%-15.3%
Q4 '24$60.1M-$5.1M$-0.0384.2%-8.5%
Q3 '24$54.3M-$15.7M$-0.1175.0%-29.0%
Q2 '24$48.1M-$15.0M$-0.1078.2%-31.2%
Get Your Daily Market Recap